Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,050.97

1.79 (0.17%)

, GOOGL

Alphabet Class A

$1,060.34

4.7 (0.45%)

12:14
11/27/18
11/27
12:14
11/27/18
12:14

YouTube launches student plans for Music and YouTube Premium

In an earlier blog posting, Google's YouTube said: "Today, we're introducing new student plans for YouTube Music and YouTube Premium, giving eligible university and college students discounted access to a world of music, original series and movies - all ad-free and at a wallet-friendly price...Student plans are available for YouTube Music Premium for $4.99 and YouTube Premium for $6.99. Students who sign up by 1/31/19 can lock in YouTube Premium at a special rate of just $5.99." Reference Link

GOOG

Alphabet

$1,050.97

1.79 (0.17%)

GOOGL

Alphabet Class A

$1,060.34

4.7 (0.45%)

  • 28

    Nov

  • 29

    Nov

  • 03

    Mar

GOOG Alphabet
$1,050.97

1.79 (0.17%)

11/21/18
PIPR
11/21/18
NO CHANGE
Target $157
PIPR
Overweight
Amended Verily agreement 'major win' for DexCom holders, says Piper Jaffray
After talking with management, Piper Jaffray analyst JP McKim believes the amended collaboration and license agreement with Alphabet's (GOOG, GOOGL) Verily "seems like a no brainer" and is a "major win for the long term value" of DexCom (DXCM) shareholders. The royalty payments from the original agreement have been eliminated and those would have been at least a 500 basis point headwind on the margin profile of DexCom's business, McKim tells investors in a research note. He expects the company to release some longer term margin targets at its analyst day and says "removing this future headwind is a major win." Further, DexCom is now the preferred continuous glucose monitoring supplier into Onduo's Type 2 diabetes management program, says the analyst. He reiterates an Overweight rating on the shares with a $157 price target.
11/21/18
SPHN
11/21/18
NO CHANGE
Target $170
SPHN
Overweight
Verily collaboration more favorable to DexCom after revision, says Stephens
Stephens analyst Chris Cooley said DexCom's (DXCM) revised agreement with Alphabet's (GOOGL) Verily makes DexCom the preferred CGM partner while also replacing the former royalty agreement with an enhanced equity stake. The revised pact "solidifies the long-term potential of the collaboration while setting-up a more favorable EBITDA profile" for DexCom, contends Cooley, who keeps an Overweight rating and $170 price target on DexCom shares.
11/26/18
BARD
11/26/18
NO CHANGE
BARD
Outperform
Baird suggests M&A targets for Google to boost cloud ambitions
Baird analyst Colin Sebastian said he continues to view Google (GOOGL) as fully capable of addressing the entire public cloud opportunity, but its progress has been a bit slower than he expected, noting that the company is still the number-three player in the cloud platform market. The analyst believes the company should embark on a more aggressive "shopping spree" to improve commercialization and compiled a list of suggestions for compatible and complementary acquisitions that met his criteria to be "game-changing" based on core product/service, enterprise reputations, growth profile, and post-integration potential. The list of Sebastian and Baird software analyst Rob Oliver includes Workday (WDAY), ServiceNow (NOW), Atlassian (TEAM), Salesforce (CRM), Zendesk (ZEN), LogMeIn (LOGM), Tableau (DATA) and Box (BOX), he tells investors in a note titled "Google Should Lead Another Cloud Consolidation Wave." Sebastian maintains an Outperform rating on shares of Google parent Alphabet.
11/26/18
KEYB
11/26/18
NO CHANGE
KEYB
AWS revenue could double to $56B-plus by 2021, says KeyBanc
KeyBanc analyst Brent Bracelin notes that the annual November trek to Las Vegas for AWS (AMZN) reInvent commences on Tuesday. The analyst believes 2019 could mark the first year AWS adds an incremental $10B within a single year as cloud and digital transformation becomes a mainstream phenomena driving AWS revenue to $35B-plus and operating profits above $10B for the first time. Looking out three years to 2021, Bracelin estimates AWS revenue could double to an estimated $56B-plus from $25B this year. Even at that scale, this would assume AWS might capture just 4% share of a trillion-dollar market leaving ample room for IaaS alternative platforms like Microsoft Azure (MSFT) and Google Cloud (GOOG; GOOGL) to also sustain high-growth at scale, he contends. Bottom line, the analyst believes AWS is likely to remain a bright spot within the broad Amazon product portfolio from both a revenue growth and profitability perspective during a cloud-first era.
GOOGL Alphabet Class A
$1,060.34

4.7 (0.45%)

11/26/18
MKMP
11/26/18
NO CHANGE
Target $190
MKMP
Buy
MKM Partners lowers price targets on Alphabet and Facebook
MKM Partners analyst Rob Sanderson lowers his price target on Alphabet (GOOGL) to $1,365 from $1,465 and on Facebook (FB) to $190 from $230 as part of his broader research note for the Internet Applications and Media sector. The analyst states that both of these stocks have been underperforming the Nasdaq on 1-month, 3-month, and year-to-date basis, but believes that Alphabet's underperformance has more to do with a rotation away from growth given its "remarkably consistent" performance and its expected moderating traffic acquisition rate costs. Sanderson says that while Facebook stock is the "furthest from its intrinsic value", it continues to face a "challenging event path with engagement shift toward lower monetizing apps" and the expected cost increase to build greater "safety and security competencies". He also believes that Facebook business model will normalize at "much lower profit margin" because of these added costs. The analyst keeps Alphabet and Facebook ratings at Buy. As part of his research note, Sanderson also maintains a Buy rating on Twitter (TWTR) with a price target of $43. The analyst contends that the company has "compelling upside potential as monetization catches up to engagement growth", with added optionality coming from potential "service breaks-through to the mass market."

TODAY'S FREE FLY STORIES

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
09/16/19
09/16
16:20
09/16/19
16:20
Options
Closing CBOE SPX and VIX Index summary for September 16th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LHCG

LHC Group

$118.42

0.8 (0.68%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Initiation
LHC Group initiated  »

LHC Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 13

    Nov

ABEO

Abeona Therapeutics

$3.00

0.035 (1.18%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Hot Stocks
Great Point Partners reports 5.7% passive stake in Abeona Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECPG

Encore Capital

$35.05

0.66 (1.92%)

16:19
09/16/19
09/16
16:19
09/16/19
16:19
Hot Stocks
Encore Capital appoints Tracy Ting Chief Human Resources Officer »

Encore Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$99.32

-0.19 (-0.19%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Initiation
Nasdaq initiated  »

Nasdaq initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ZGNX

Zogenix

$41.87

0.28 (0.67%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
Great Point Partners reports 5.3% passive stake in Zogenix »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPTI

OPTi Inc.

$0.00

(0.00%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
OPTi Inc. in 'strategic' pact with DR Microgrids »

OPTEC International forms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$29.45

-0.46 (-1.54%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Conference/Events
Arrowhead management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

16:18
09/16/19
09/16
16:18
09/16/19
16:18
Hot Stocks
Aclaris says Phase 3 trial meets all primary, secondary endpoints »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$30.09

-0.01 (-0.03%)

16:17
09/16/19
09/16
16:17
09/16/19
16:17
Hot Stocks
SeaWorld CEO Gustavo Antorcha resigns, Marc Swanson named interim CEO »

SeaWorld announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
09/16/19
09/16
16:17
09/16/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
09/16/19
09/16
16:16
09/16/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$77.36

-0.74 (-0.95%)

16:16
09/16/19
09/16
16:16
09/16/19
16:16
Conference/Events
Addus HomeCare management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

16:15
09/16/19
09/16
16:15
09/16/19
16:15
Hot Stocks
Tonix Pharmaceuticals announces licensing pact with Columbia University »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 25

    Sep

XOM

Exxon Mobil

$73.76

1.13 (1.56%)

, CVX

Chevron

$124.13

2.67 (2.20%)

16:14
09/16/19
09/16
16:14
09/16/19
16:14
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks were lower, and…

XOM

Exxon Mobil

$73.76

1.13 (1.56%)

CVX

Chevron

$124.13

2.67 (2.20%)

WLL

Whiting Petroleum

$11.23

3.7 (49.14%)

DNR

Denbury Resources

$1.56

0.35 (28.93%)

XOG

Extraction Oil & Gas

$4.17

0.95 (29.50%)

CDEV

Centennial Resource Development

$5.80

1.39 (31.52%)

GM

General Motors

$37.19

-1.64 (-4.22%)

NXST

Nexstar

$107.16

5.03 (4.93%)

TRCO

Tribune Media

$46.65

0.03 (0.06%)

BX

Blackstone

$53.51

-0.04 (-0.07%)

MGM

MGM Resorts

$29.69

0.65 (2.24%)

CNHI

CNH Industrial

$11.17

-0.03 (-0.27%)

ALDR

Alder Biopharmaceuticals

$18.68

8.63 (85.87%)

SEMG

SemGroup

$16.50

6.22 (60.51%)

ET

Energy Transfer LP

$13.41

-0.6 (-4.28%)

NEWR

New Relic

$58.44

0.1 (0.17%)

MNK

Mallinckrodt

$3.01

-0.29 (-8.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 23

    Sep

  • 26

    Sep

  • 26

    Sep

  • 08

    Oct

  • 09

    Oct

  • 21

    Oct

  • 07

    Nov

  • 13

    Nov

  • 21

    Feb

APA

Apache

$28.46

4.13 (16.97%)

16:14
09/16/19
09/16
16:14
09/16/19
16:14
Initiation
Apache initiated  »

Apache initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 13

    Nov

ALDR

Alder Biopharmaceuticals

$18.59

8.54 (84.98%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Downgrade
Alder Biopharmaceuticals rating change  »

Alder Biopharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 21

    Feb

CME

CME Group

$207.10

1.35 (0.66%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Initiation
CME Group initiated  »

CME Group initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$91.87

1.04 (1.15%)

16:13
09/16/19
09/16
16:13
09/16/19
16:13
Initiation
IntercontinentalExchange initiated  »

IntercontinentalExchange…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

NDAQ

Nasdaq

$99.21

-0.3 (-0.30%)

16:12
09/16/19
09/16
16:12
09/16/19
16:12
Initiation
Nasdaq initiated  »

Nasdaq initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CBOE

Cboe Global Markets

$111.07

0.21 (0.19%)

16:11
09/16/19
09/16
16:11
09/16/19
16:11
Initiation
Cboe Global Markets initiated  »

Cboe Global Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBCP

Concrete Pumping

$4.33

0.195 (4.72%)

16:10
09/16/19
09/16
16:10
09/16/19
16:10
Earnings
Concrete Pumping sees FY19 revenue $284M, consensus 292.54M »

The company now expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

BBCP

Concrete Pumping

$4.33

0.195 (4.72%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Earnings
Concrete Pumping reports Q3 EPS 5c, consensus 7c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

MRVL

Marvell

$25.42

-0.43 (-1.66%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Marvell's Gaynor sells 35,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAST

Eastside Distilling

$4.99

-0.01 (-0.20%)

16:07
09/16/19
09/16
16:07
09/16/19
16:07
Hot Stocks
Eastside Distilling acquires Azunia Tequila in all-stock transaction »

Eastside Distilling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.